137 related articles for article (PubMed ID: 9014859)
1. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas.
Harvey P; Warn A; Newman P; Perry LJ; Ball RY; Warn RM
J Pathol; 1996 Dec; 180(4):389-94. PubMed ID: 9014859
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma.
Tolnay E; Kuhnen C; Wiethege T; König JE; Voss B; Müller KM
J Cancer Res Clin Oncol; 1998; 124(6):291-6. PubMed ID: 9692834
[TBL] [Abstract][Full Text] [Related]
3. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
Jeffers M; Rong S; Anver M; Vande Woude GF
Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
[TBL] [Abstract][Full Text] [Related]
4. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
5. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
[TBL] [Abstract][Full Text] [Related]
6. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
7. Expression of Met protein in thyroid tumours.
Ruco LP; Ranalli T; Marzullo A; Bianco P; Prat M; Comoglio PM; Baroni CD
J Pathol; 1996 Nov; 180(3):266-70. PubMed ID: 8958803
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
[TBL] [Abstract][Full Text] [Related]
9. c-met proto-oncogene expression in benign and malignant human prostate tissues.
Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity for cadherins, HGF/SF, met, and erbB-2 in pleural malignant mesotheliomas.
Thirkettle I; Harvey P; Hasleton PS; Ball RY; Warn RM
Histopathology; 2000 Jun; 36(6):522-8. PubMed ID: 10849094
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
Lindemann K; Resau J; Nährig J; Kort E; Leeser B; Annecke K; Welk A; Schäfer J; Vande Woude GF; Lengyel E; Harbeck N
Histopathology; 2007 Jul; 51(1):54-62. PubMed ID: 17593080
[TBL] [Abstract][Full Text] [Related]
12. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.
Otsuka T; Takayama H; Sharp R; Celli G; LaRochelle WJ; Bottaro DP; Ellmore N; Vieira W; Owens JW; Anver M; Merlino G
Cancer Res; 1998 Nov; 58(22):5157-67. PubMed ID: 9823327
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of VEGF, c-Met and HGF/SF in secondary pleural tumors.
Naim R; Tolnay E; Mueller KM; Kuhnen C
Int J Mol Med; 2004 Nov; 14(5):787-91. PubMed ID: 15492846
[TBL] [Abstract][Full Text] [Related]
14. [c-Met and HGF expression in non-small-cell lung carcinomas].
Korobko IV; Zinov'eva MV; Allakhverdiev AK; Zborovskaia IB; Svwrdlov ED
Mol Gen Mikrobiol Virusol; 2007; (2):18-21. PubMed ID: 17598453
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma.
Tsukinoki K; Yasuda M; Mori Y; Asano S; Naito H; Ota Y; Osamura RY; Watanabe Y
Oncol Rep; 2004 Nov; 12(5):1017-21. PubMed ID: 15492787
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis.
Furukawa T; Duguid WP; Kobari M; Matsuno S; Tsao MS
Am J Pathol; 1995 Oct; 147(4):889-95. PubMed ID: 7573364
[TBL] [Abstract][Full Text] [Related]
17. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
[TBL] [Abstract][Full Text] [Related]
18. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
Briggs MC; Grierson I; Hiscott P; Hunt JA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
Tuck AB; Park M; Sterns EE; Boag A; Elliott BE
Am J Pathol; 1996 Jan; 148(1):225-32. PubMed ID: 8546209
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells.
Tsao MS; Zhu H; Giaid A; Viallet J; Nakamura T; Park M
Cell Growth Differ; 1993 Jul; 4(7):571-9. PubMed ID: 8398897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]